FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Avoid Tissue Agnostic Therapy Unintended Consequence: PhRMA

Stakeholders suggest things to be considered in developing tissue agnostic therapies.

Human Drugs

FDA Lifts Clinical Hold on Solid Bioscience Trial

FDA lifts a clinical hold against Solid Biosciences Phase 1/2 clinical trial for its investigational microdystrophin gene transfer, SGT-001, for treat...

Medical Devices

FDA Clears Arcuro Medical Meniscus Repair Device

FDA clears an Arcuro Medical 510(k) for its SuperBall meniscus repair system.

Human Drugs

Clinical Hold Placed on Ziopharm Leukemia Trial

FDA issues a clinical hold on a Ziopharm Oncology Phase 1 trial to evaluate CD19-specific CAR-T therapies manufactured under point-of-care, and reques...

Human Drugs

Canada Should Curb U.S. Drug Patents in Trade War: Professor

University of Ottawa law professor Amir Attaran suggests that the Canadian government should look at suspending U.S. drug patents as the Trump Adminis...

Federal Register

Comments Sought on Drug/Biologic Data Standard

Federal Register notice: FDA establishes a public docket to receive information, recommendations, and comments on matters related to its publication o...

Human Drugs

Info Collection Extension for Biosimilar Meetings Guidance

Federal Register notice: FDA announces an opportunity for public comment on an information collection extension for the agency guidance entitled Forma...

Federal Register

Draft Guide on Epidermolysis Bullosa Drugs

Federal Register notice: FDA has made available a draft guidance entitled Epidermolysis Bullosa (EB): Developing Drugs for Treatment of Cutaneous Mani...

Human Drugs

Complete Response Letter on Ortho Psoriasis Lotion

FDA issues Ortho Dermatologics a complete response letter on its NDA for Duobrii (halobetasol propionate and tazarotene) lotion and its use in treatin...

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 6/15/2018.